|Published (Last):||28 May 2007|
|PDF File Size:||8.39 Mb|
|ePub File Size:||13.31 Mb|
|Price:||Free* [*Free Regsitration Required]|
We'd like to understand how you use our websites in order to improve them. Register your interest. The minimal effective dose of gestodene for inhibition of ovulation was studied in 30 female volunteers. A control cycle prior to treatment and a treatment cycle were monitored for LH, FSH, estradiol, progesterone and cervical score. This triphasic gestodene-containing preparation inhibited ovulation in all 20 females. Data from this investigation suggest that this triphasic gestodene-containing OC has a high contraceptive efficacy.
This is a preview of subscription content, log in to check access. Lachnit-Fixson U. Development and clinical evaluation of triphasic oral contraception. In: Elstein M, ed. Update on triphasic oral contraception. Amsterdam: Excerpta Medica. Google Scholar. Synthesen von Gestoden Drug Res. Acta Obstet Gynecol Scand. Gestodene a new direction in oral contraception. Elstein M. Gestodene: Development of a new gestodene-containing low-dose oral contraceptive. The rationale for a new triphasic contraceptive.
In: Greenblatt RB, ed. The development of a new triphasic oral contraceptive. Ovulation inhibition with different doses of levonorgestrel and other progestagens: clinical and experimental investigation. Endocrine-pharmacological profile of gestodene. Clinical experiences with a modern low-dose oral contraceptive in almost users. Mode of action of triphasic oral contraception. Triphasic combination of ethinylestradiol and gestodene. Long-term clinical trial.
Effects of seven low dose combined oral contraceptives on ovarian function, measured by ultrasound examination and peripheral endocrine parameters. Multicenter clinical trials on triphasic gestodene. Triphasic Gestodene. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter randomized comparative trial. Am J Obstet Gynecol. Download references. Reprints and Permissions. Spona, J. Inhibition of ovulation by a triphasic gestodene-containing oral contraceptive.
Adv Contracept 9, — Download citation. Received : 09 April Accepted : 05 May Issue Date : September Search SpringerLink Search. Abstract The minimal effective dose of gestodene for inhibition of ovulation was studied in 30 female volunteers. References 1. Spona View author publications. You can also search for this author in PubMed Google Scholar. View author publications. Rights and permissions Reprints and Permissions. About this article Cite this article Spona, J.
Translation of "inadequate luteal" in French
E-mail : jean-luc. Endometrial hyperplasias can be divided into two categories based on the presence or absence of cytological atypia and further classified as simple or complex according to the extent of architectural abnormalities. They are usually diagnosed because of irregular bleeding in perimenopause. Hysteroscopy with a biopsy gives a more accurate diagnosis than transvaginal ultrasonography, sonohysterography, or blind curettage. Endometrial hyperplasias with no cytological atypia, regarded as a response to unopposed endogenous estrogenic stimulation, are normally treated with progestins. The intra-uterine route levonorgestrel intra-uterine system is more effective and better tolerated than the oral route.
Inhibition of ovulation by a triphasic gestodene-containing oral contraceptive